MoonLake Immunotherapeutics (MLTX) Pension (2021 - 2026)

MoonLake Immunotherapeutics' Pension history runs 6 years deep, the most recent figure standing at $353000.0 for Q1 2026.

• On a quarterly basis, Pension fell 34.14% year-over-year to $353000.0 in Q1 2026; TTM through Mar 2026 was $353000.0, a 34.14% decrease from a year earlier, with the FY2024 full-year figure at $621000.0, down 75.1% from the prior year.
• Pension eased to $353000.0 in Q1 2026 per MLTX's latest filing, from $549000.0 in the prior quarter.
• Across five years, Pension topped out at $2.5 million in Q4 2023 and bottomed at $4985.0 in Q3 2022.
• The 5-year median for Pension is $536000.0 (2025), against an average of $604359.1.
• Across the five-year window, Pension surged 5023.35% in 2023 and sank 75.1% in 2024, its largest moves.
• Year by year, Pension stood at $1.3 million in 2022, then jumped by 88.65% to $2.5 million in 2023, then sank by 75.1% to $621000.0 in 2024, then decreased by 11.59% to $549000.0 in 2025, then plunged by 35.7% to $353000.0 in 2026.
• Per Business Quant, the three latest MLTX Pension figures stand at $353000.0 (Q1 2026), $549000.0 (Q3 2025), and $574000.0 (Q2 2025).